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Abstract
Trypanosoma cruzi the agent of Chagas disease is a monophyletic but heterogeneous group conformed by several Discrete
Typing Units (DTUs) named TcI to TcVI characterized by genetic markers. The trans-sialidase (TS) is a virulence factor
involved in cell invasion and pathogenesis that is differentially expressed in aggressive and less virulent parasite stocks.
Genes encoding TS-related proteins are included in a large family divided in several groups but only one of them contains
TS genes. Two closely related genes differing in a T/C transition encode the enzymatically active TS (aTS) and a lectin-like TS
(iTS). We quantified the aTS/iTS genes from TcII and TcVI aggressive and TcI low virulent strains and found variable aTS
number (1–32) per haploid genome. In spite of being low TS enzyme-expressers, TcI strains carry 28–32 aTS gene copies.
The intriguing absence of iTS genes in TcI strains together with the presence of aTS/iTS in TcII and TcVI strains (virulent)
were observed. Moreover, after sequencing aTS/iTS from 38 isolates collected along the Americas encompassing all DTUs,
the persistent absence of the iTS gene in TcI, TcIII and TcIV was found. In addition, the sequence clustering together with T/
C transition analysis correlated to DTUs of T. cruzi. The consistence of TS results with both evolutionary genome models
proposed for T. cruzi, namely the ‘‘Two Hybridization’’ and the ‘‘Three Ancestor’’ was discussed and reviewed to fit present
findings. Parasite stocks to attempt genetic KO or to assay the involvement of iTS in parasite biology and virulence are
finally available.
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Introduction
Chagas disease is a chronic disabling disease caused by the
protozoon Trypanosoma cruzi. With an estimated 8–10 million
people already infected, and about 40,000 new cases/year, Chagas
disease represents a major public health, social and economic
problem in Latin America where about 100 million people are at
risk [1]. Besides the vectorial spread, blood transfusion, organ
transplants and congenital transmission increase the worldwide
dissemination risk due to migratory processes as in the USA where
it has been estimated that 300,000 people are infected [2].
T. cruzi constitutes a monophyletic but genetically heteroge-
neous group. Based on various genetic markers and evolutive and
population genetics interpretations of data, T. cruzi populations
have been classified into six Discrete Typing Units (DTU) namely
TcI to TcVI. Recently a seventh group sampled in bats and
named TcBat has been added [3,4]. Because of the predominantly
clonal evolution of the parasite, these DTUs are rather stable in
space and time, constituting a useful framework for epidemiolog-
ical and evolutionary analysis [5]. This genetic diversity seems to
be correlated with a geographical distribution [3,6,7] and with
biological characteristics of the parasite such as culture growth,
pathogenicity in mice, evolution in the insect vector, susceptibility
to antichagasic drugs and tissular tropism in animal and human
infections. Human infection displays different clinical evolutions
ranging from asymptomatic to cardiomyopathy, megaviscera or
even death. Different outcome incidences are also determined by
host genetics, the presence of mixed infections, cultural factors, etc.
[8]. Within the endemic area, heterogeneous geographical
distribution of DTUs has been extensively described suggesting
that the genetic composition of the parasite could be partly
responsible for the different manifestations of Chagas disease.
Broadly, TcI is found from the south of the USA in the sylvatic
environment to northern South America where it seems to be
responsible for chagasic cardiomyopathy [7,9–11]. In Southern
Cone countries, TcI is usually associated to the sylvatic cycle
whereas TcII, TcV, and TcVI are relatively more abundant than
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TcI in the domestic cycle [3,12,13]. In this region, human
infections present higher rates of severe heart affectation [7,14–18]
and digestive abnormalities, which are exceptional in northern
South America and Central America [19,20]. TcIII which is
usually isolated from vectors and sylvatic reservoirs has a low
prevalence in human infections [11,21,22] whereas TcIV shows a
similar geographical distribution but higher incidence in human
infection [15,23–25].
Although sialic acid is crucial for the life cycle of T. cruzi, being
involved in host cell adhesion/invasion processes and escape from
the complement, the parasite is unable to synthesize this sugar de
novo. To circumvent this gap, the parasite expresses the trans-
sialidase (TS), that transfers a(2,3)-linked sialyl residues among
glycoproteins or glycolipids. Circulating TS activity alters the
sialylation pattern of the cellular glycoconjugates leading to
hematological and immunological abnormalities associated to
the disease [26–28].
Genes encoding TS are included in a large family composed of
at least 1439 members [29], a figure certainly underestimated due
to the expected collapse when assembling closely similar sequenc-
es. Although several different groups of genes can be discerned,
only one of them includes those that code for the TS proteins
[30,31]. It has been estimated that as many as 150 genes of this
group are included in the genome [32] where two TS isoforms, the
active enzyme (aTS) and an enzymatically inactive TS (iTS) are
encoded. Comparison of the aTS vs. iTS deduced amino acid
sequences shows variations in 20 residues, although the inactiva-
tion is entirely due to the single crucial Tyr342His replacement as a
consequence of a T/C transition [33]. The replacement by
histidine renders the protein enzymatically inactive but allows
retaining the substrate binding ability conferring therefore a lectin-
like activity [32,34]. This strongly suggests a physiologic role for
iTS in parasite attachment to substrates or cell surface receptors
that might explain its conservation. Crystallographic analyses and
enzyme kinetic assays [35] have recently shown that iTS retains
residual hydrolytic activity. By using the recombinant iTS, a co-
stimulating host T-cells effect have been adscribed [36].
Previous efforts to associate parasite genetic classification and
biological features have allowed us to determine the expression/
shed of aTS as a marker of pathogenicity that segregates strains
belonging to different lineages [37]. In this study our aim was to
analyze the distribution of genes encoding the virulence factor TS
among DTU-representative isolates collected along the Americas
in the context of their evolution. We found aTS in all analyzed
stocks and the striking absence of iTS genes in TcI, TcIII and
TcIV DTUs. The consistence of the TS results with current T.
cruzi evolutionary genome models was reviewed to fit findings.
Parasite stocks to attempt genetic KO or to assay the involvement
of iTS in parasite biology and virulence are now available.
Materials and Methods
Trypanosoma cruzi isolates
The study was carried out in a panel of 38 parasite isolates
encompassing all DTUs (nine TcI stocks, seven TcII, two TcIII,
five TcIV, six TcV, and nine TcVI) obtained from various
ecological origins (vectors, animal reservoirs and human infections)
spanning all the endemic area from Argentina to the USA.
Trypanosoma cruzi genomic DNA purification
DNA from Ac, Hc, K-98, SN, Br, CMA, ChVal, HE, HT, RA,
Q501/3, Tulahuen, ML, Alf, FAL and Cvd parasite strains was
obtained from peripheral blood trypomastigotes. DNA from Silvio
X10, Tu18, M5631, Can III, CL Brener, CID, H1, QUE,
CBBcl2, ESMcl3Z2, IVVcl4, MAS1cl1, MVBcl8, X109/2, 3.1,
92122102R, STC10R, STC16Rcl1, MNcl2, SC43cl1, CA15,
P63cl1 strains was obtained from epimastigotes. The Blood and
Cell Culture DNA Purification Kit (Qiagen) or conventional
phenol-chloroform DNA extraction methods were used.
DTU characterization
All T. cruzi DNA samples were genotyped using polymerase
chain reaction (PCR) strategies following Burgos et al [17]
algorithm of classification. Some T. cruzi stocks (CID, H1, QUE,
CBBcl2, ESMcl3Z2, IVVcl4, MAS1cl1, MVBcl8, X109/2, 3.1,
92122102R, STC10R, STC16Rcl1, MNcl2, SC43cl1, CA15,
P63cl1) were also characterized by MLEE [38–40] for DTU
assignment.
For PCR characterization, five reactions targeted to the
intergenic region of spliced leader genes (SL-IR), 24sa rDNA
and the A10 fragment were carried out on each DNA sample to
determine the parasite DTU. The PCR amplicon size for each
DTU was: Tc I: SL-IRac (150 bp), SL-IR-I (475 bp), and 24sa
HnPCR (140 bp); TcII: SL-IRac (157 bp), SL-IR-II (425 bp),
24sa HnPCR (140 bp) and A10-PCR (690 bp); TcIII: SL-IRac
(200 bp), 24sa HnPCR (125 bp), and A10-PCR (630 bp); TcIV:
SL-IRac (200 bp) and 24sa HnPCR (140/145 bp); TcV: SL-IRac
(157 bp), SL-IR-II (425 bp), 24sa HnPCR (125 or 125+140 bp),
and A10-PCR (630 bp); TcVI: SL-IRac (157 bp), SL-IR-II
(425 bp), 24sa HnPCR (140 bp), and A10-PCR (630 bp).
Quantification of aTS and iTS genes
To assess the number of genes per haploid genome coding for
aTS and iTS in each parasite isolate, a real-time PCR-based
strategy was applied. These assays were performed at the facilities
of Eurofins Medigenomix GmbH (Germany) on an ABI 7900 HT
Sequence Detection System (Applied Biosystems) using the
universal mix of ABI TaqMan reagents (Applied Biosystems).
Briefly, the region containing the mutation was amplified with the
following flanking oligonucleotides: 5’-TGGGCAAGTATC-
CATTGGTGATG-3’ and 5’-TGATCTCATGCAAACAGTA-
CAGCTT-3’. In the same reaction, a pair of fluorescent-labeled
probes specific for the two possible sequences at the mutation
position (59-AATTCCGCCTACAGCT-39 coupled to FAM to
detect aTS and 59-AAAATTCCGCCCACAGCT-39 coupled to
VIC which binds to iTS) allowed the quantification of both genes.
The analysis was normalized by quantification of the T. cruzi
pyruvate dehydrogenase (PVDH)-encoding gene present as a
single copy per haploid genome [41]. This reaction included a set
of primers (5’-CGGCGTACCAGCCTGAGAT-3’ and 5’-AC-
CTGAAGGCCCGGAATG-3’) and a labeled probe (5’-
TACCGTCGTGGCGACT-3’) that hybridizes the pvdh gene.
Plasmids containing the aTS or iTS genes were used as control
and during test standardization. In the data analysis, the intensity
of each signal was a definite value (Ct, cycle of threshold), which is
inversely related to the amount of complementary DNA. The
proportion of both genes was calculated for each T. cruzi isolate as
the average of two independent determinations.
Amplification and sequencing of TS genes
Two upstream and two downstream primers to the region
containing the T/C transition of TS-encoding genes were
designed (59 primers: TS-51, 59-GGAGGCTGTCGG-
CACGCTCTC-39 and TS-5, 59-GCTTCACTGCCGTGAC-
CATCG-39; 39 primers: TS-31, 59-TCACGCAGCGGTACG-
CATCCT-39 and TS-3, 59-CAGCGGGACCACAACCACGCT-
39), so that all the TS sequences annotated in the GenBank were
targeted in at least one of the four PCR reactions to be performed.
Trans-Sialidase Genes in T. cruzi Populations
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Amplification was carried out with 0.4 mM of each primer, 5 U of
Pfu polymerase enzyme (Promega), 2.5 mM of dNTPs, and 100 ng
of genomic T. cruzi DNA as template in 50 ml final reaction
volume. The PCR cycle consisted of 30 rounds of 94uC for 45 s,
63uC for 45 s, and 72uC for 45 s, with a first step of 2 min at 94uC
and one last step of 5 min at 72uC. PCR products were analyzed
by electrophoresis in 2% agarose gel. Amplicons were purified and
both strands sequenced with the primers used for amplification.
Chromatograms were visually examined to determine the
presence of C and/or T in the first position of the codon 342.
Firstly TS-51/TS-31 primer set was used and those genomes
rendering only the Tyr342 codon were then subjected to the other
three PCR reactions. The IUPAC nomenclature for the genetic
code was used to define single nucleotide polymorphism (SNP)
positions with mixed base identification set to 15% of the highest
peak. Sequences were deposited in the GenBank with the
accession numbers KC286514, KC286515, KC286516,
KC286517, KC286518, KC286519, KC286520, KC286521,
KC286522, KC286523, KC286524, KC286525, KC286526,
KC286527, KC286528, KC286529, KC286530, KC286531,
KC286532, KC286533, KC286534, KC286535, KC286536,
KC286537, KC286538, KC286539, KC286540, KC286541,
KC286542, KC286543, KC286544, KC286545, KC286546,
KC286547, KC286548, KC286549, KC294586 and KC294587.
Sequence comparison of the region around the codon
342
A 455-bp consensus sequence of each T. cruzi stock was
obtained by comparison of forward and reverse sequences of the
TS-51/TS-31 PCR reactions. Sequences from the different stocks
were aligned and compared by using ClustalW2 program [42]. A
clustering tree was built by using SplitsTree4 [43] with the
following options: i) the ‘‘UncorrectedP’’ method which computes
the proportion of positions at which two sequences differ was used;
ii) the ambiguous state codes (such as W, M, V …) were handled
with the option ‘Average’ meaning that the contribution at a site is
averaged over all possible resolutions of the ambiguous codes, with
the exception that sites having the same ambiguous code
contribute zero; iii) the distance-based method used was UPGMA
because we considered that evolution rate must be the same upon
all branches; the bootstrap was conducted with 1,000 iterations.
Results
Quantification of aTS and iTS genes in the genome of T.
cruzi
To analyze the distribution of TS-encoding genes in the genome
of parasites analyzed by Risso et al [37], we performed a
quantitative analysis of aTS and iTS by real-time PCR on DNA
samples. The single copy Pvdh gene [41] was included as internal
reference to standardize the number of haploid genome copies in
the test. Primers that amplify the region containing the single
nucleotide polymorphism (SNP) that determines the loss of
enzymatic activity were used together with two probes that differ
in only one base (T/C transition) and comprise the Tyr codon (to
hybridize aTS genes) or His codon (complementary to the
sequence of iTS genes), respectively. No cross-recognition between
the aTS and iTS probes under test conditions was found, as
assayed with plasmids harboring the corresponding gene. No Ct
could be determined with the iTS-complementary probe for low-
virulence TcI strains, indicating no detection of iTS genes carrying
the T/C transition. As shown in Table 1, the genome of these T.
cruzi isolates harbors 28 to 32 copies of aTS-coding genes. On the
other hand, data obtained from the aggressive strains RA, Cvd,
CL Brener and the clone Q501/3 (all belonging to TcVI) and Br
(TcII) indicated that both the aTS and iTS genes were present with
high variability in the gene copy number (Table 1). In these
genomes, the aTS/iTS rate was high for TcII (3/1) and quite
balanced in TcVI (2/1 and 1/1).
Presence of the T/C SNP in codon 342 of TS genes
The findings presented above strongly suggest the intriguing
absence of iTS genes in TcI parasite genome. To further test the
differential distribution of aTS and iTS among T. cruzi stocks
belonging to different DTUs, the T/C SNP was directly searched
by sequencing PCR-amplified gene fragments comprising the
surrounding region. To assess the representation of the Tyr342His
mutation among these different parasite stocks, two primers were
designed upstream and two other downstream the target codon.
All TS genes deposited at GenBank were covered given that all
these known sequences were targeted at least once in the PCR
strategy designed. Table 2 summarizes the biological sources and
geographical origins of the parasite isolates tested and the findings
observed. Notably, whereas all stocks from the DTUs TcII, TcV
and TcVI contained both aTS and iTS genes (with T and C in the
Table 1. Quantification of aTS and iTS in parasites representing high and low TS activity producers.
T. cruzi pvdh aTS iTS
DTU Isolatea Ct Ct Gene copies Ct Gene copies
TcI Ac 39.00460.606 23.90760.146 30 (100%) ND 0
Hc 34.17260.098 18.47360.001 32 (100%) ND 0
K-98 36.52960.186 22.67960.102 28 (100%) ND 0
TcII Br 18.26960.022 16.91260.032 3 (75%) 17.61160.029 1 (25%)
TcVI RA 28.92560.018 14.76760.065 28 (64%) 20.90060.877 16 (36%)
Q501/3 20.46560.155 17.71760.066 4 (67%) 19.04360.048 2 (33%)
Cvd 17.79160.094 17.07460.378 1 (50%) 17.86760.159 1 (50%)
CL Brener 29.13260.161 14.71960.032 29 (60%) 19.49460.141 19 (40%)
a) Parasites correspond to low (TcI) and high (TcII and TcVI) TS activity producer stocks as described by Risso et al [37].
Parasite DNA was subjected to quantitative real time PCR and aTS/iTS presence was determined by using probes labeled with reporter dyes. Gene number per haploid
genome was determined by Ct comparison with that obtained for the pvdh single copy gene. Ct: cycle of threshold; ND: not detectable.
doi:10.1371/journal.pone.0058967.t001
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first position encoding codon 342 observed as a mixed peak in the
chromatograms, see Figure 1), TcI, TcIII and TcIV parasites
tested depicted only T (corresponding to aTS genes) indicating the
absence of genes coding for iTS in agreement with results shown in
Table 1.
Sequence comparison of TSs amplicons
To further analyze the region in search for other SNPs that
might be useful to classify parasites, we compared the 455 bp TS
gene region sequenced from the 38 T. cruzi stocks belonging to the
six DTUs. Besides the nucleotide position corresponding to the T/
C transition (Figure 1), sequences also include the TGG codon for
Trp312, one of the two aromatic residues that participate in
substrate binding [35]. Interestingly, all stocks from every DTU
encoded the Trp312 codon sequence in that position (see Figure
S1). On the other hand, sequences revealed several differences
among the six DTUs as other SNPs beyond the T/C transition.
Nine SNPs were synapomorphs of DTUs or groups of DTUs.
Based on these SNPs and other less conserved polymorphisms
(asterisks in Figure S1), the sequence clustering analysis as an
UPGMA tree (Figure 2) showed that parasite strains were
differentiated into six groups that coincide with the previous
DTU assignment, TcI, TcII, TcIII, TcIV, TcV and TcVI with
only two exceptions (CANIII and 3.1 strains which are classified as
TcIV but here clustered with TcIII). However, bootstrap values
were remarkably significant for TcI, TcIII and TcIV and lower
(,50) for the other DTUs.
Discussion
The T. cruzi current classification into six principal DTUs,
mainly based on genetic characteristics, proved to be a valid
framework to study the biological variability of T. cruzi that is
widely recognized [3]. Indeed genetic diversity of the parasite is
undoubtedly an important factor influencing many biological
parameters (reviewed in [3]), and it has been suggested that it
could be partly responsible for the different clinical outcomes of
Chagas disease [8]. No strong correlation has yet been observed
between the development of pathology and parasite’s DTUs.
However, most clinical and epidemiological studies in human
infections associate TcI with infections in patients living from
Colombia northwards, whereas TcII, TcV and TcVI have been
detected as the most prevalent etiological agents at the south of
South America, where Chagas disease presents high rates of severe
heart affectation [15–18]. In particular, digestive syndromes, also
observed in southern countries, appear to be associated only to
TcII, TcV and TcVI parasites [19,20]. Although T. cruzi
populations display differential virulence and pathogenic charac-
teristics, genetic markers linked with the evolution of the infection
and their outcomes have not been identified to date. Different
efforts have been made to find virulence factors that correlate with
the current parasite classification [37,44–46]. A recent study [47]
has shown differential expression of 29 out of 261 proteins that are
overexpressed in T. cruzi stocks belonging to a given DTU. We
have previously shown [26,37] that virulent parasites currently
studied that belong to TcII or TcVI, express/shed more TS
activity than the less aggressive TcI stocks. In addition, increased
circulating TS activity correlates with several abnormalities
observed early during the infection [26,28]. The involvement of
shed aTS in the alterations of the histoarchitecture of the spleen,
thymus and ganglia, as well as in the induction of thrombocyto-
penia has been evaluated by both the administration of
recombinant aTS to naive mice and the neutralization of the
enzymatic activity during the acute infection [26,28,48]. Here the
fine quantitative SNP mapping allowed us to identify aTS/iTS
differences that remain hidden in genomic analyses [49] because
iTS genes are not included in databases taken as reference. The
present quantification of TS genes in parasite stocks exposed the
absence of iTS genes together with the presence of similar copy
number of aTS in all TcI parasite stocks tested (28 to 32 copies/
Table 2. Origin and DTU classification of parasite isolates
with TS isoforms predicted presence.
T. cruzi isolate Source Countrya/Area DTU TSb
Ac Human Ar/Chaco I aTS
Hc Human Ar/unknown I aTS
SN Human Ar/Misiones I aTS
K-98 Human Ar/San Luis I aTS
FAL Human Ar/Chaco I aTS
Silvio X10 Human Br/Para I aTS
CID Human Me/Oaxaca I aTS
H1 Human Me/Yucatan I aTS
QUE Vectorc Me/Queretaro I aTS
Br Human Ar/unknown II aTS/iTS
Tu18 Vectord Bo/Tupiza II aTS/iTS
CBBcl2 Human Ch/Region IV II aTS/iTS
IVVcl4 Human Ch/Region IV II aTS/iTS
MVBcl8 Human Ch/Region IV II aTS/iTS
ESMcl3 Human Br/Bahia II aTS/iTS
MAS1cl1 Human Br/Fed. District II aTS/iTS
M5631 Armadilloe Br/I. Marajo III aTS
X109/2 Dog Pa/Pte. Hayes III aTS
Can III Human Br/Belem IV aTS
3.1 Vectord Pe/Arequipa IV aTS
92122102R Raccoon USA/Georgia IV aTS
STC10R Raccoon USA/Georgia IV aTS
STC16Rcl1 Raccoon USA/Georgia IV aTS
CMA Human Ar/Chaco V aTS/iTS
ChVAL Human Ar/unknown V aTS/iTS
HE Human Ar/Chaco V aTS/iTS
HT Human Ar/Chaco V aTS/iTS
MNcl2 Human Ch/Region IV V aTS/iTS
SC43cl1 Vectord Bo/Chuquisaca V aTS/iTS
RA Human Ar/Chaco VI aTS/iTS
Q501/3 Human Ch/Region IV VI aTS/iTS
Cvd Human Ar/Mendoza VI aTS/iTS
ALF Human Ar/Chaco VI aTS/iTS
ML Human Ar/unknown VI aTS/iTS
Tulahuen Human Ch/Region IV VI aTS/iTS
CL Brener Vectord Br/RG do Sul VI aTS/iTS
CA15 Vectord Bo/Santa Cruz VI aTS/iTS
P63cl1 Vectord Pa/Pte. Hayes VI aTS/iTS
a) Ar: Argentina; Br: Brasil; Me: Me´xico; Bo: Bolivia; Ch: Chile; Pe: Peru´; Pa:
Paraguay. b) TS isoforms predicted presence. aTS: active trans-sialidase; iTS
inactive trans-sialidase. c) unidentified blood-sucking vector; d) Triatoma
infestans (vector bug). e) Dasypus novemcinctus.
doi:10.1371/journal.pone.0058967.t002
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haploid genome). On the other hand, variable aTS and iTS copy
number (from 1 to 29 and 1 to 19 copies/haploid genome,
respectively) were found in TcII and TcVI. These DTUs showed
an aTS/iTS ratio that ranged from 1 to 3 (Table 1). These current
observations allow us to conclude that the actual protein
expression is independent of the number of aTS genes because
genomes from high aTS producer parasites contain similar or even
lower aTS gene copy numbers than those from TcI parasites with
little production of aTS [37]. Moreover, the absence of iTS genes
in this group raises the possibility of a correlation between this gap
and the lower virulence previously observed for the TcI parasites
assayed [37]. Considering that the aggressive strains [37] contain
genes encoding iTS isoform, a role for this protein in the virulent
behavior could be inferred. The analysis of iTS/aTS genes was
then extended to representative parasite stocks encompassing the
six DTUs, isolated from several sources (insect vectors, animal
reservoirs and human infections) in different geographical areas
(from the USA to Argentina). We found that aTS genes were
present in all 38 parasite populations, emphasizing the central role
of this enzyme in parasite biology. It is worth noting that iTS was
observed exclusively in stocks from DTUs TcII, TcV and TcVI
but intriguingly absent in all TcI, TcIII and TcIV stocks analyzed.
The absence of cumulated mutations or stop codons in iTS
sequences, together with the fact that we have always found the
same T/C transition that encodes the Tyr342His amino acid
replacement as the enzyme inactivation mechanism, indicate that
the same iTS genes, conserved among all the TcII, TcV and TcVI
parasite populations, are probably expressed. The Trp312 and Tyr
119 codons that are crucial in creating the two-aromatic residue-
stacking site for the galactosyl portion of the substrate [50] are also
conserved in aTS and iTS proteins from all DTUs. In support, a
residual enzyme activity has been recently found for iTS protein
[35] emphasizing that it has similar properties to aTS in sequence
and folding. Furthermore, in vitro assays have demonstrated the co-
stimulatory properties of iTS proteins on the immune system [36].
The strong sequence conservation in all iTS genes supports that
Figure 1. Chromatograms from the region flanking the T/C
SNP. Sequencing examples from parasites belonging to the six DTUs
are shown. Black arrow points T and C nucleotides in TcII, TcV and TcVI
PCR products. Empty arrow points the same position in TcI, TcIII and
TcIV amplicons, where only T was observed. Star indicates a T/G SNP (K
in IUPAC code) present in all tested parasites.
doi:10.1371/journal.pone.0058967.g001
Figure 2. UPGMA tree based on TS genes sequence alignment (with ambiguous states). Each circle grouped all 38 T. cruzi strains in their
respective previous assigned DTU, except CAN III and 3.1 that were previously assigned to TcIV. Significant bootstrap values for TcI, TcIII and TcIV are
reported, bootstrap values for other DTUs were ,50.
doi:10.1371/journal.pone.0058967.g002
Trans-Sialidase Genes in T. cruzi Populations
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iTS plays an evolutionary selectable role, instead of representing
just a collection of pseudogenes. Therefore, an involvement in
parasite attachment/invasion to host cells can be postulated
because iTS acts as a lectin, able to bind not only small
oligosaccharides but also sialylated glycoproteins [32,34], a
relevant feature in the physiological scenario of parasite infection.
Interestingly, our findings also reveal the existence of parasites
with highly reduced TS genes content that provide models to
develop genomic KO, a largely expected tool to extend the study
of the biological relevance of TS whose generation has been
hampered by the high gene copy numbers always reported for TS.
Moreover, the ongoing transfection assays with the iTS gene might
provide with a nice opportunity to test the actual relevance of iTS
in parasite biology and pathogenesis.
In 2009, an expert committee revised the information available
about T. cruzi evolution and clustering. They remember that the
partition of T. cruzi in six principal DTUs could be explained by
two alternative models for their origin: the ‘Two Hybridization’
model giving rise to TcIII and then to TcV and TcVI through
hybridization of two ancestors (TcI and TcII) [51] and the ‘Three
Ancestor’ where the ancestors TcI, TcII and TcIII gave rise to the
hybrids TcV and TcVI [52]. The current distribution of aTS/iTS
suggests a closer relationship of TcI with TcIII-TcIV than with the
other DTUs as well as a related evolution of TcII, TcV and TcVI.
Indeed, the sequence analysis that reflect the variability of a set of
genes coding for the same virulence factor (TS) fits with the six
DTUs clustering, although TcII, TcV and TcVI DTU were not
supported by significant bootstrap values because the hybrid
nature of TcV and TcVI, reduces the bootstrap values, and if these
strains are removed from the analysis (see Figure S2), TcI and TcII
DTUs are everyone very well supported by high bootstrap value
(93.8 and 98.3 respectively), and TcIII and TcIV are grouped
together with a lower bootstrap value (60.9). However, this group
is further divided into two clusters, one including CanIII, M5631,
X109/2 and 3.1 strains (bootstrap value of 95.8) and the other
comprising STC16Rcl1, STC10R and 92122102R strains (boot-
strap value of 71.4). Although several scenarios can explain the
current variability of the TS genes within DTUs, considering that
TcI and TcII are ancestors [51,52] and that iTS may have
originated from aTS genes through a single mutation event, the
common ancestor of TcI and TcII should not have had iTS. After
iTS consolidation in TcII, its delivery during subsequent hybrid-
ization events could explain its presence in TcV and TcVI
parasites (newest hybrid groups [51,52]). Further, considering the
‘‘Two Hybridization’’ model, the absence of iTS in TcIII and
TcIV could be explained by an inequitable ancient recombination,
gene conversion or by loss of iTS corresponding genes. In the
‘‘Three Ancestor’’ model [52] TcIII-TcIV could have early
diverged from TcI and propagated without iTS genes. The close
relationship between TcIII and IV with TcI is also supported by
findings with cruzipain and TSSA antigens [45,53]. As shown in
Figure 3, an alternative picture of T. cruzi evolution might be
drawn that fits the previously obtained data plus that reported
here. Ancestor parasites lack iTS, then TcII acquired iTS and both
TcI and TcII became ancestors of all the other DTUs. A single
hybridization event is postulated between TcII and TcIII that
rendered TcV and VI, TcIII and IV seem to have evolved from
TcI instead from hybridization of TcI with TcII because this
hypothesis requires two events, the hybridization itself followed by
the lost of the iTS genes contributed by TcII genome.
Finding an association between clinical manifestations and
parasite genotype is a difficult task. The multiclonal nature of most
natural infections and the histotropic behavior of different
parasites lead to partial characterizations when bloodstream
and/or other infected tissue samples are analyzed [54,55]. The
regional diversity of Chagas disease outcomes has been attributed
to a set of complex interactions where the parasite genetic makeup,
as well as the environmental and the host immunogenetic
background are some of the factors involved (reviewed by [56]).
In the challenge to identify links between the infecting DTUs and
the pathogenesis induced by T. cruzi we presented for the first time
the differential distribution among parasite populations of iTS/
aTS, a virulence factor-related gene that is well correlated with the
evolutionary history of the parasite. The expression of this
complex (aTSa/iTS) of virulent genes may be a key to better
understand the mechanism of virulence and its relationship with T.
cruzi evolution.
Supporting Information
Figure S1 Consensus sequence of TS gene internal
region. Sequence alignment of T. cruzi stocks encompassing the
6 DTUs (TcI to TcVI). (.): conserved sites; (.): SNPs that identify
a group of parasites (inter-DTU polymorphism). In those positions,
depicted nucleotide for each DTU was present in all sequences
obtained from all parasites of each DTU (named as IUPAC code);
(*): other polymorphic positions not shared by all stocks within a
DTU (intra-DTU polymorphisms); TGG: Trp312 codon conserved
in all stocks from all DTUs; Box: Tyr342His codon where
Thymidine (encoding Tyr) and Cytosine (encoding His) are
present in all stocks belonging to TcII, TcV and TcVI whereas
only Thymidine was found in TcI, TcIII and TcIV genomes. No
other mutations were found in this codon.
(TIF)
Figure S2 UPGMA tree based on TS genes sequence
alignment (with ambiguous states) not including hybrid
DTUs. To avoid deviations induced by the hybrid nature of T.
cruzi TcV and TcVI DTUs, UPGMA tree was built excluding
these DTUs.
(TIF)
Figure 3. Parasite DTU evolution model proposed. Considering
the previously proposed evolution models [3] together with data
reported here, an evolution model is drawn where the acquisition of the
iTS gene by a single mutation event by TcII places TcI and TcII as the
only ancestors for all the other DTUs. A single hybridization event of
TcIII and TcII derivates in TcV and VI as previously proposed.
doi:10.1371/journal.pone.0058967.g003
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